| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $0 (Miss by $-0.33) |
| EPS GAAP Actual | $0 (Miss by $-0.33) |
| Revenue Actual | $1.331B |
| Revenue Surprise | Beat by $1331M |
| Announce Date | 03/31/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.23 |
| EPS GAAP Estimate | $0.23 |
| Revenue Estimate | $1.382032B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 3 |
| Dec 2027 | 1.28 | 15.26 | 1.24615 | 1.32296 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.23 | 0.23 | 1.331B | 0.9% | 1331M |
| FQ2 2025 (Jun 2025) | 0.32 | 0.32 | 1.586B | 7.57% | 1586M |
| FQ1 2025 (Mar 2025) | 0.35 | 0.35 | 1.594B | 7.72% | 1594M |
| FQ4 2024 (Dec 2024) | 0.15 | 0.15 | 1.428B | 7.35% | 1428M |
| FQ3 2024 (Sep 2024) | 0.12 | 0.12 | 1.319B | 7.96% | 1319M |
| FQ2 2024 (Jun 2024) | 0.34 | 0.34 | 1.466B | 4.98% | 1466M |
| FQ1 2024 (Mar 2024) | 0.38 | 0.38 | 1.471B | 6.12% | 1471M |
| FQ4 2023 (Dec 2023) | 0.19 | 0.19 | 1.323B | 4.54% | 1323M |
FQ4 Announce Date
03/31/2026 (Pre-Market)
Consensus EPS Estimates
0.23
Consensus Revenue Estimates
1.382032B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.21 | -- | 0.1956 | 0.22619 | 1 |
| FQ3 2027 (Sep 2027) | 0.08 | -- | 0.07451285 | 0.08616752 | 1 |
| FQ2 2027 (Jun 2027) | 0.32 | -- | 0.29805 | 0.34467 | 1 |
| FQ1 2027 (Mar 2027) | 0.35 | -- | 0.32599 | 0.37698 | 1 |
| FQ4 2026 (Oct 2026) | 0.16 | -- | 0.15559 | 0.16777 | 3 |
| FQ3 2026 (Jul 2026) | 0.33 | 30.3 | 0.3209 | 0.34602 | 3 |
| FQ2 2026 (Jun 2026) | 0.31 | -3.23 | 0.28874 | 0.3339 | 1 |
| FQ1 2026 (Mar 2026) | 0.23 | -52.17 | 0.22366 | 0.24117 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.52B | -- | 1.44B | 1.61B | 3 |
| FQ3 2027 (Sep 2027) | 1.39B | -- | 1.32B | 1.47B | 3 |
| FQ2 2027 (Jun 2027) | 1.64B | -- | 1.55B | 1.73B | 3 |
| FQ1 2027 (Mar 2027) | 1.62B | -- | 1.54B | 1.72B | 3 |
| FQ4 2026 (Oct 2026) | 1.33B | -- | 1.3B | 1.38B | 10 |
| FQ3 2026 (Jul 2026) | 1.51B | 11.62 | 1.47B | 1.56B | 10 |
| FQ2 2026 (Jun 2026) | 1.62B | 1.81 | 1.53B | 1.71B | 5 |
| FQ1 2026 (Mar 2026) | 1.38B | -15.34 | 1.35B | 1.43B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.23 | 0.23 | 100% | |
| FQ2 2025 (Jun 2025) | 0.32 | 0.32 | 100% | |
| FQ1 2025 (Mar 2025) | 0.35 | 0.35 | 100% | |
| FQ4 2024 (Dec 2024) | 0.15 | 0.15 | 100% | |
| FQ3 2024 (Sep 2024) | 0.12 | 0.12 | 100% | |
| FQ2 2024 (Jun 2024) | 0.34 | 0.34 | 100% | |
| FQ1 2024 (Mar 2024) | 0.38 | 0.38 | 100% | |
| FQ4 2023 (Dec 2023) | 0.19 | 0.19 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.33B | $1331M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.59B | $1586M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.59B | $1594M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.43B | $1428M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.32B | $1319M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.47B | $1466M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.47B | $1471M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.32B | $1323M | 100% |